Abstract
The pharmacology and chemotherapy of a new penicillin, 6[D(—)-α-aminophenylacetamido] penicillanic acid, are described. It is non-toxic, is absorbed orally and is distributed throughout the body in a manner similar to other penicillins. It is eliminated unchanged from the body in high concentrations in the bile and urine. Almost all of the antibiotic can be accounted for in the urine and intestinal contents 2 hr after intramuscular administration but not after oral administration. It is concluded that the antibiotic is not metabolized within the body. Studies with infected animals show that it is as effective as the existing oral penicillins against Staphylococcus pyogenes Smith (penicillin sensitive), Streptococcus pyogenes Group A and Diplococcus pneumoniae. It is ineffective against penicillin-resistant Staphylococci. When tested in mice infected with the gram-negative organisms, Salmonella tryphimurium and Klebsiella pneumoniae, it was considerably more active than tetracycline and chloramphenicol.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- ACRED P., BROWN D. M., TURNER D. H., WRIGHT D. Pharmacology of methicillin. Br J Pharmacol Chemother. 1961 Aug;17:70–81. doi: 10.1111/j.1476-5381.1961.tb01105.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown D. M., Acred P. "Penbritin"-A New Broad-spectrum Antibiotic. Br Med J. 1961 Jul 22;2(5246):197–198. doi: 10.1136/bmj.2.5246.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HANSON D. J. Local toxic effects of broad-spectrum antibiotics following injection. Antibiot Chemother (Northfield) 1961 Jun;11:390–404. [PubMed] [Google Scholar]
- KNUDSEN E. T., ROLINSON G. N., STEVENS S. Absorption and excretion of "Penbritin". Br Med J. 1961 Jul 22;2(5246):198–200. doi: 10.1136/bmj.2.5246.198. [DOI] [PMC free article] [PubMed] [Google Scholar]